Work

Gemcitabine and bendamustine is a safe and effective salvage regimen for patients with recurrent/refractory Hodgkin lymphoma: Results of a phase 1/2 study

Year: 2019

Type: article

Study design: Clinical Trial

Source: Cancer

DOI: 10.1002/cncr.32640

Authors: Jonathon B. Cohen, Lai Wei, Kami J. Maddocks, Beth Christian, Leonard T. Heffner, Amelia A. Langston, Mary Jo Lechowicz, Pierluigi Porcu, Christopher R. Flowers, Steven M. Devine, Kristie A. Blum

Institutions: Emory University, Winship Cancer Institute, The Ohio State University, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Lymphoma Research Foundation, American Society of Hematology, Teva Pharmaceutical Industries, National Cancer Institute

Award: Development of a comprehensive research program in mantle cell lymphoma in the ibrutinib era

OpenAlex ID: W2995493095

FWCI: 1.11

Cites: 22

Cited by: 8

Related to: 10